eHealthMe - FDA and Social Media, Personalized eHealthMe - FDA and Social Media, Personalized

FDA and Social Media, Personalized


Advanced tools       Explore eHealthMe

From FDA reports: drug interactions between Omeprazole, Flagyl, Ofloxacin, Ranitidine Hydrochloride for a Female patient aged 56

This is a personalized study for a 56 year old female patient. The study is created by eHealthMe based on reports of 7 people who take the same drugs and have drug interactionsfrom FDA.

On Aug, 18, 2014: 7 people who reported to have interactions when taking Omeprazole, Flagyl, Ofloxacin, Ranitidine Hydrochloride are studied

Trend of Omeprazole, Flagyl, Ofloxacin, Ranitidine Hydrochloride's drug interactions, side effects, and effectiveness reports (1333446)

Information of the patient in this study:

Age: 56

Gender: female

Conditions: Gastroenteritis Helicobacter

Drugs taking:
- Omeprazole: used for 1 - 6 months
- Flagyl
- Ofloxacin
- Ranitidine Hydrochloride

Drug interactions have: Dermatitis Bullous, Drug Ineffective, Erythema Multiforme, Rash Vesicular, Toxic Epidermal Necrolysis, Toxic Skin Eruption

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 56 (±5):

InteractionNumber of reports
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)2 (100.00%)
Drug Ineffective2 (100.00%)
Erythema Multiforme (type of hypersensitivity reaction)2 (100.00%)
Rash Vesicular (rash with a small bubble)2 (100.00%)
Toxic Epidermal Necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)2 (100.00%)
Toxic Skin Eruption (skin breakdown due to toxic substance)2 (100.00%)

Most common interactions experienced by females aged 56 (±5) in the use of Omeprazole, Flagyl, Ofloxacin, Ranitidine Hydrochloride:

InteractionNumber of reports
Toxic Epidermal Necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)2
Erythema Multiforme (type of hypersensitivity reaction)2
Drug Ineffective2
Rash Vesicular (rash with a small bubble)2
Toxic Skin Eruption (skin breakdown due to toxic substance)2
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)2

Most common interactions experienced by females aged 56 (±5) in long term use of Omeprazole, Flagyl, Ofloxacin, Ranitidine Hydrochloride:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Dermatitis Bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)2 (28.57%)
Drug Ineffective6 (85.71%)
Erythema Multiforme (type of hypersensitivity reaction)6 (85.71%)
Rash Vesicular (rash with a small bubble)2 (28.57%)
Toxic Epidermal Necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)7 (100.00%)
Toxic Skin Eruption (skin breakdown due to toxic substance)2 (28.57%)

Most common interactions experienced by people in the use of Omeprazole, Flagyl, Ofloxacin, Ranitidine Hydrochloride:

InteractionNumber of reports
Drug Ineffective6
Choking (mechanical obstruction of the flow of air from the environment into the lungs)6
Sepsis Nos6
Oedema Peripheral (superficial swelling)4
Cardiac Pacemaker Insertion4
Tardive Dyskinesia (a disorder that involves involuntary movements)4
Headache (pain in head)4
Bundle Branch Block (disruption in the normal flow of electrical pulses that drive the heart beat)4
Chest Pain4
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)4

Most common interactions experienced by people in long term use of Omeprazole, Flagyl, Ofloxacin, Ranitidine Hydrochloride:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

 

Recent mobile support groups

- Constipation and Pyorrhea - Gum Disease

- Quetiapine Fumarate for Bipolar Ii Disorder

- Hair Loss and Gabapentin

- Shortness Of Breath and Lorazepam

- Vomiting and Fibromyalgia

 

Recent user comments

- "Nerve damage to shoulder. Compressed discs c5 and c7. " (4 hours ago)

- "High Blood pressure Pulmonary Embolism approximately ... " (5 hours ago)

- "lips have been sort of numb and eyes feel like they a ... " (6 hours ago)

 

Recent searches

- Thrombocytopenia
- Propecia
- Gastric Irritation
- Seroquel Xr
- Lamictal

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.